Bausch + Lomb provides three-year plan at investor day

Bausch + Lomb (BLCO) will outline the next chapter of its evolution during an investor day event at the New York Stock Exchange. During the event, Bausch + Lomb leadership will unveil plans to achieve above-market revenue growth and meaningful margin expansion. The company’s target of 5%-7% constant currency revenue CAGR through 2028 is expected to be driven by holistic growth in its base business and recent product launches across the spectrum of eye health needs. The company’s target of approximately 23% adjusted EBITDA margin in 2028 is expected to be fueled by continuous improvements to how it sources, makes and sells products, and an ongoing examination of opportunities to streamline internal processes. Bausch + Lomb will also announce additional financial targets of double-digit adjusted annual earnings per share growth from 2026 – 2028, approximately 50% adjusted cash flow from operations to adjusted EBITDA conversion in 2028 and net leverage of approximately 3.5x by the end of 2028.